+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Next-Generation IVD Market by Product Type (Instruments, Reagents & Kits, Software & Services), Technology (Clinical Chemistry, Immunoassay, Microbiology), End User, Application, Test Type, Sample Type - Global Forecast 2025-2030- Product Image
Next-Generation IVD Market by Product Type (Instruments, Reagents & Kits, Software & Services), Technology (Clinical Chemistry, Immunoassay, Microbiology), End User, Application, Test Type, Sample Type - Global Forecast 2025-2030- Product Image
Sale

Next-Generation IVD Market by Product Type (Instruments, Reagents & Kits, Software & Services), Technology (Clinical Chemistry, Immunoassay, Microbiology), End User, Application, Test Type, Sample Type - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 184 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5925182
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The next-generation in vitro diagnostics (IVD) market is undergoing rapid transformation as healthcare systems worldwide invest in advanced technologies that improve disease detection and management. Senior leaders face increasing pressure to adopt solutions that balance high-quality outcomes, operational efficiency, and cost controls amid shifting regulatory and demographic trends.

Market Snapshot: Next-Generation IVD Market Size and Growth

The Next-Generation IVD Market grew from USD 65.60 billion in 2024 to USD 69.24 billion in 2025. It is expected to continue growing at a CAGR of 5.30%, reaching USD 89.44 billion by 2030.

Scope & Segmentation

This report delivers an in-depth look at the competitive and technological landscape through comprehensive segmentation and geographical analysis.

  • Product Types: Instruments, Reagents & Kits, Software & Services
  • Instruments: Chemistry Analyzers, Immunoassay Analyzers, PCR Instruments
  • Reagents & Kits: Clinical Chemistry Reagents, Immunoassay Reagents, Molecular Diagnostics Reagents
  • Software & Services: Data Management Software, Maintenance Services
  • Technology Platforms: Clinical Chemistry (Electrochemical, Photometric), Immunoassay (Clia, Elisa, Fia), Microbiology (Culture Based, Molecular), Molecular Diagnostics (Isothermal Amplification, PCR Based, Sequencing Based)
  • End Users: Diagnostic Laboratories, Hospitals & Clinics, Point Of Care, Research Institutes
  • Applications: Autoimmune Disease, Cardiology, Infectious Disease, Neurology, Oncology
  • Test Types: Qualitative, Quantitative, Semi Quantitative
  • Sample Types: Blood, Saliva, Tissue, Urine
  • Regional Coverage: Americas, Europe Middle East & Africa, Asia Pacific
  • Profiling Companies: F. Hoffmann-La Roche Ltd., Abbott Laboratories, Siemens Healthineers AG, Danaher Corporation, Thermo Fisher Scientific Inc., Becton, Dickinson and Company, bioMérieux SA, Sysmex Corporation, QIAGEN N.V., Mindray Medical International Limited

Key Takeaways for Senior Decision-Makers

  • Technological advancements are redefining IVD by integrating high-throughput chemistry, advanced immunoassay, and next-generation sequencing with powerful data analytics platforms.
  • Personalized medicine trends, heightened quality standards, and increased healthcare workloads drive the need for multiplex assays, digital monitoring tools, and scalable reagent solutions.
  • Players are strategically focusing on digital service ecosystems, creating value beyond instrument sales and supporting predictive clinical insights.
  • Point-of-care expansion and regulatory harmonization, especially in emerging markets, are increasing both diagnostic capacity and competitive complexity.
  • Mature markets prioritize decentralized testing and value-based care, while collaborative partnerships enable rapid adaptation to evolving payer expectations and health system needs.
  • The report highlights the changing dynamics between centralized and decentralized testing, with companies adapting product roadmaps and forming alliances to capture new opportunities across care settings.

Tariff Impact: Navigating 2025 Supply Chain Headwinds

Heightened United States tariffs in 2025 introduced notable challenges for IVD manufacturers. Increased duties on key instruments and reagent imports prompted vendors to diversify procurement, negotiate longer-term raw material contracts, and invest in domestic production strategies. Modular instrument design and enhanced service models are helping firms address cost volatility while reinforcing resilient, agile supply chains.

Market Research Methodology & Data Sources

Research combines secondary intelligence from peer-reviewed publications, regulatory filings, and patent data with primary interviews involving industry leaders and healthcare payers. Data triangulation and expert validation fortify the analytical frameworks, ensuring qualitative and quantitative insights accurately reflect current and anticipated market trends.

Why This Report Matters to Industry Leaders

  • Offers actionable intelligence aligned with crucial purchasing and technology investment decisions in next-generation IVD.
  • Enables strategic planning by highlighting regional market dynamics, partner opportunities, and evolving regulatory settings.
  • Equips decision-makers to strengthen value propositions and mitigate risk across rapidly changing diagnostic ecosystems.

Conclusion

Next-generation IVD solutions are reshaping diagnostics and care delivery. Strategic planning and cross-industry collaboration will determine competitive advantage as market dynamics continue to evolve. Organizations prepared to adapt will maximize value and maintain relevance in this pivotal sector.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of artificial intelligence and machine learning algorithms to improve sensitivity and specificity of point-of-care IVD diagnostics
5.2. Development of multiplexed microfluidic platforms enabling simultaneous detection of multiple biomarkers in a single patient sample
5.3. Adoption of digital health connectivity in IVD devices for real-time remote monitoring and data analytics integration
5.4. Advancement of CRISPR-based gene editing techniques for ultrafast highly specific detection of pathogenic nucleic acids in clinical samples
5.5. Rising use of novel nanomaterials such as quantum dots and gold nanoparticles for signal amplification in next-generation immunoassays
5.6. Expansion of decentralized testing models leveraging smartphone-based sensors for at-home infectious disease screening
5.7. Growth of personalized medicine initiatives driving demand for companion diagnostic assays tailored to targeted therapies
5.8. Regulatory shifts emphasizing stringent validation standards and accelerated approval pathways for innovative IVD technologies
5.9. Increasing focus on sustainable and disposable IVD cartridge designs to minimize biohazard waste and environmental footprint
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Next-Generation IVD Market, by Product Type
8.1. Introduction
8.2. Instruments
8.2.1. Chemistry Analyzers
8.2.2. Immunoassay Analyzers
8.2.3. PCR Instruments
8.3. Reagents & Kits
8.3.1. Clinical Chemistry Reagents
8.3.2. Immunoassay Reagents
8.3.3. Molecular Diagnostics Reagents
8.4. Software & Services
8.4.1. Data Management Software
8.4.2. Maintenance Services
9. Next-Generation IVD Market, by Technology
9.1. Introduction
9.2. Clinical Chemistry
9.2.1. Electrochemical
9.2.2. Photometric
9.3. Immunoassay
9.3.1. Clia
9.3.2. Elisa
9.3.3. Fia
9.4. Microbiology
9.4.1. Culture Based
9.4.2. Molecular
9.5. Molecular Diagnostic
9.5.1. Isothermal Amplification
9.5.2. PCR Based
9.5.3. Sequencing Based
10. Next-Generation IVD Market, by End User
10.1. Introduction
10.2. Diagnostic Laboratories
10.2.1. Hospital Laboratories
10.2.2. Reference Laboratories
10.3. Hospitals & Clinics
10.3.1. Secondary Care Hospitals
10.3.2. Tertiary Care Centers
10.4. Point Of Care
10.5. Research Institutes
11. Next-Generation IVD Market, by Application
11.1. Introduction
11.2. Autoimmune Diseases
11.2.1. Celiac
11.2.2. Lupus
11.2.3. Rheumatoid Arthritis
11.3. Cardiology
11.3.1. Cardiac Markers
11.3.2. Lipids
11.4. Infectious Diseases
11.4.1. COVID-19
11.4.2. Hepatitis
11.4.3. Hiv
11.4.4. Tuberculosis
11.5. Neurology
11.5.1. Alzheimer’s Disease
11.5.2. Parkinson’s Disease
11.6. Oncology
11.6.1. Hematological
11.6.2. Solid Tumor
12. Next-Generation IVD Market, by Test Type
12.1. Introduction
12.2. Qualitative
12.3. Quantitative
12.4. Semi Quantitative
13. Next-Generation IVD Market, by Sample Type
13.1. Introduction
13.2. Blood
13.3. Saliva
13.4. Tissue
13.5. Urine
14. Americas Next-Generation IVD Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Next-Generation IVD Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Next-Generation IVD Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. F. Hoffmann-La Roche Ltd.
17.3.2. Abbott Laboratories
17.3.3. Siemens Healthineers AG
17.3.4. Danaher Corporation
17.3.5. Thermo Fisher Scientific Inc.
17.3.6. Becton, Dickinson and Company
17.3.7. bioMérieux SA
17.3.8. Sysmex Corporation
17.3.9. QIAGEN N.V.
17.3.10. Mindray Medical International Limited
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. NEXT-GENERATION IVD MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL NEXT-GENERATION IVD MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY TEST TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES NEXT-GENERATION IVD MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES NEXT-GENERATION IVD MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION IVD MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION IVD MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC NEXT-GENERATION IVD MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC NEXT-GENERATION IVD MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. NEXT-GENERATION IVD MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. NEXT-GENERATION IVD MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. NEXT-GENERATION IVD MARKET: RESEARCHAI
FIGURE 28. NEXT-GENERATION IVD MARKET: RESEARCHSTATISTICS
FIGURE 29. NEXT-GENERATION IVD MARKET: RESEARCHCONTACTS
FIGURE 30. NEXT-GENERATION IVD MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. NEXT-GENERATION IVD MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL NEXT-GENERATION IVD MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL NEXT-GENERATION IVD MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY CHEMISTRY ANALYZERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY CHEMISTRY ANALYZERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY IMMUNOASSAY ANALYZERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY IMMUNOASSAY ANALYZERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY PCR INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY PCR INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY CLINICAL CHEMISTRY REAGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY CLINICAL CHEMISTRY REAGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY IMMUNOASSAY REAGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY IMMUNOASSAY REAGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY MOLECULAR DIAGNOSTICS REAGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY MOLECULAR DIAGNOSTICS REAGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY REAGENTS & KITS, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY REAGENTS & KITS, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY MAINTENANCE SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY MAINTENANCE SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY CLINICAL CHEMISTRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY CLINICAL CHEMISTRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY ELECTROCHEMICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY ELECTROCHEMICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY PHOTOMETRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY PHOTOMETRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY CLINICAL CHEMISTRY, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY CLIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY CLIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY ELISA, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY ELISA, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY FIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY FIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY MICROBIOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY MICROBIOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY CULTURE BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY CULTURE BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY MOLECULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY MOLECULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY MICROBIOLOGY, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY MICROBIOLOGY, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY MOLECULAR DIAGNOSTIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY MOLECULAR DIAGNOSTIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY PCR BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY PCR BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY SEQUENCING BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY SEQUENCING BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY MOLECULAR DIAGNOSTIC, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY MOLECULAR DIAGNOSTIC, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY HOSPITAL LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY HOSPITAL LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY SECONDARY CARE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY SECONDARY CARE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY TERTIARY CARE CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY TERTIARY CARE CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY HOSPITALS & CLINICS, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY POINT OF CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY POINT OF CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY CELIAC, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY CELIAC, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY LUPUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY LUPUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY AUTOIMMUNE DISEASES, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY CARDIOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY CARDIAC MARKERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY CARDIAC MARKERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY LIPIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY LIPIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY CARDIOLOGY, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY CARDIOLOGY, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY COVID-19, BY REGION, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY COVID-19, BY REGION, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY HEPATITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY HEPATITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY HIV, BY REGION, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY HIV, BY REGION, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY TUBERCULOSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY TUBERCULOSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 131. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 132. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY NEUROLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 133. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY ALZHEIMER’S DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 134. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY ALZHEIMER’S DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 135. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY PARKINSON’S DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 136. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY PARKINSON’S DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 137. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 138. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 139. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 140. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 141. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY HEMATOLOGICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 142. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY HEMATOLOGICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 143. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY SOLID TUMOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 144. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY SOLID TUMOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 145. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 146. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 147. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 148. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 149. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY QUALITATIVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 150. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY QUALITATIVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 151. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY QUANTITATIVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 152. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY QUANTITATIVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 153. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY SEMI QUANTITATIVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 154. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY SEMI QUANTITATIVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 155. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 156. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 157. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY BLOOD, BY REGION, 2018-2024 (USD MILLION)
TABLE 158. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY BLOOD, BY REGION, 2025-2030 (USD MILLION)
TABLE 159. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY SALIVA, BY REGION, 2018-2024 (USD MILLION)
TABLE 160. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY SALIVA, BY REGION, 2025-2030 (USD MILLION)
TABLE 161. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY TISSUE, BY REGION, 2018-2024 (USD MILLION)
TABLE 162. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY TISSUE, BY REGION, 2025-2030 (USD MILLION)
TABLE 163. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY URINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 164. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY URINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 165. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 166. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 167. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 168. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 169. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY REAGENTS & KITS, 2018-2024 (USD MILLION)
TABLE 170. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY REAGENTS & KITS, 2025-2030 (USD MILLION)
TABLE 171. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
TABLE 172. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2030 (USD MILLION)
TABLE 173. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 174. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 175. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2024 (USD MILLION)
TABLE 176. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY CLINICAL CHEMISTRY, 2025-2030 (USD MILLION)
TABLE 177. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 178. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 179. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY MICROBIOLOGY, 2018-2024 (USD MILLION)
TABLE 180. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY MICROBIOLOGY, 2025-2030 (USD MILLION)
TABLE 181. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY MOLECULAR DIAGNOSTIC, 2018-2024 (USD MILLION)
TABLE 182. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY MOLECULAR DIAGNOSTIC, 2025-2030 (USD MILLION)
TABLE 183. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 184. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 185. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 186. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 187. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2024 (USD MILLION)
TABLE 188. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY HOSPITALS & CLINICS, 2025-2030 (USD MILLION)
TABLE 189. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 190. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 191. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2024 (USD MILLION)
TABLE 192. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY AUTOIMMUNE DISEASES, 2025-2030 (USD MILLION)
TABLE 193. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY CARDIOLOGY, 2018-2024 (USD MILLION)
TABLE 194. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY CARDIOLOGY, 2025-2030 (USD MILLION)
TABLE 195. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 196. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 197. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 198. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 199. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 200. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 201. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 202. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 203. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 204. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 205. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 206. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 207. UNITED STATES NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 208. UNITED STATES NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 209. UNITED STATES NEXT-GENERATION IVD MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 210. UNITED STATES NEXT-GENERATION IVD MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 211. UNITED STATES NEXT-GENERATION IVD MARKET SIZE, BY REAGENTS & KITS, 2018-2024 (USD MILLION)
TABLE 212. UNITED STATES NEXT-GENERATION IVD MARKET SIZE, BY REAGENTS & KITS, 2025-2030 (USD MILLION)
TABLE 213. UNITED STATES NEXT-GENERATION IVD MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
TABLE 214. UNITED STATES NEXT-GENERATION IVD MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2030 (USD MILLION)
TABLE 215. UNITED STATES NEXT-GENERATION IVD MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 216. UNITED STATES NEXT-GENERATION IVD MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 217. UNITED STATES NEXT-GENERATION IVD MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2024 (USD MILLION)
TABLE 218. UNITED STATES NEXT-GENERATION IVD MARKET SIZE, BY CLINICAL CHEMISTRY, 2025-2030 (USD MILLION)
TABLE 219. UNITED STATES NEXT-GENERATION IVD MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 220. UNITED STATES NEXT-GENERATION IVD MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 221. UNITED STATES NEXT-GENERATION IVD MARKET SIZE, BY MICROBIOLOGY, 2018-2024 (USD MILLION)
TABLE 222. UNITED STATES NEXT-GENERATION IVD MARKET SIZE, BY MICROBIOLOGY, 2025-2030 (USD MILLION)
TABLE 223. UNITED STATES NEXT-GENERATION IVD MARKET SIZE, BY MOLECULAR DIAGNOSTIC, 2018-2024 (USD MILLION)
TABLE 224. UNITED STATES NEXT-GENERATION IVD MARKET SIZE, BY MOLECULAR DIAGNOSTIC, 2025-2030 (USD MILLION)
TABLE 225. UNITED STATES NEXT-GENERATION IVD MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 226. UNITED STATES NEXT-GENERATION IVD MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 227. UNITED STATES NEXT-GENERATION IVD MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 228. UNITED STATES NEXT-GENERATION IVD MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 229. UNITED STATES NEXT-GENERATION IVD MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2024 (USD MILLION)
TABLE 230. UNITED STATES NEXT-GENERATION IVD MARKET SIZE, BY HOSPITALS & CLINICS, 2025-2030 (USD MILLION)
TABLE 231. UNITED STATES NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 232. UNITED STATES NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 233. UNITED STATES NEXT-GENERATION IVD MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2024 (USD MILLION)
TABLE 234. UNITED STATES NEXT-GENERATION IVD MARKET SIZE, BY AUTOIMMUNE DISEASES, 2025-2030 (USD MILLION)
TABLE 235. UNITED STATES NEXT-GENERATION IVD MARKET SIZE, BY CARDIOLOGY, 2018-2024 (USD MILLION)
TABLE 236. UNITED STATES NEXT-GENERATION IVD MARKET SIZE, BY CARDIOLOGY, 2025-2030 (USD MILLION)
TABLE 237. UNITED STATES NEXT-GENERATION IVD MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 238. UNITED STATES NEXT-GENERATION IVD MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 239. UNITED STATES NEXT-GENERATION IVD MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 240. UNITED STATES NEXT-GENERATION IVD MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 241. UNITED STATES NEXT-GENERATION IVD MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 242. UNITED STATES NEXT-GENERATION IVD MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 243. UNITED STATES NEXT-GENERATION IVD MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 244. UNITED STATES NEXT-GENERATION IVD MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 245. UNITED STATES NEXT-GENERATION IVD MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 246. UNITED STATES NEXT-GENERATION IVD MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 247. UNITED STATES NEXT-GENERATION IVD MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 248. UNITED STATES NEXT-GENERATION IVD MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 249. CANADA NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 250. CANADA NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 251. CANADA NEXT-GENERATION IVD MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 252. CANADA NEXT-GENERATION IVD MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 253. CANADA NEXT-GENERATION IVD MARKET SIZE, BY REAGENTS & KITS, 2018-2024 (USD MILLION)
TABLE 254. CANADA NEXT-GENERATION IVD MARKET SIZE, BY REAGENTS & KITS, 2025-2030 (USD MILLION)
TABLE 255. CANADA NEXT-GENERATION IVD MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
TABLE 256. CANADA NEXT-GENERATION IVD MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2030 (USD MILLION)
TABLE 257. CANADA NEXT-GENERATION IVD MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 258. CANADA NEXT-GENERATION IVD MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 259. CANADA NEXT-GENERATION IVD MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2024 (USD MILLION)
TABLE 260. CANADA NEXT-GENERATION IVD MARKET SIZE, BY CLINICAL CHEMISTRY, 2025-2030 (USD MILLION)
TABLE 261. CANADA NEXT-GENERATION IVD MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 262. CANADA NEXT-GENERATION IVD MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 263. CANADA NEXT-GENERATION IVD MARKET SIZE, BY MICROBIOLOGY, 2018-2024 (USD MILLION)
TABLE 264. CANADA NEXT-GENERATION IVD MARKET SIZE, BY MICROBIOLOGY, 2025-2030 (USD MILLION)
TABLE 265. CANADA NEXT-GENERATION IVD MARKET SIZE, BY MOLECULAR DIAGNOSTIC, 2018-2024 (USD MILLION)
TABLE 266. CANADA NEXT-GENERATION IVD MARKET SIZE, BY MOLECULAR DIAGNOSTIC, 2025-2030 (USD MILLION)
TABLE 267. CANADA NEXT-GENERATION IVD MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 268. CANADA NEXT-GENERATION IVD MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 269. CANADA NEXT-GENERATION IVD MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 270. CANADA NEXT-GENERATION IVD MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 271. CANADA NEXT-GENERATION IVD MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2024 (USD MILLION)
TABLE 272. CANADA NEXT-GENERATION IVD MARKET SIZE, BY HOSPITALS & CLINICS, 2025-2030 (USD MILLION)
TABLE 273. CANADA NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 274. CANADA NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 275. CANADA NEXT-GENERATION IVD MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2024 (USD MILLION)
TABLE 276. CANADA NEXT-GENERATION IVD MARKET SIZE, BY AUTOIMMUNE DISEASES, 2025-2030 (USD MILLION)
TABLE 277. CANADA NEXT-GENERATION IVD MARKET SIZE, BY CARDIOLOGY, 2018-2024 (USD MILLION)
TABLE 278. CANADA NEXT-GENERATION IVD MARKET SIZE, BY CARDIOLOGY, 2025-2030 (USD MILLION)
TABLE 279. CANADA NEXT-GENERATION IVD MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 280. CANADA NEXT-GENERATION IVD MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 281. CANADA NEXT-GENERATION IVD MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 282. CANADA NEXT-GENERATION IVD MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 283. CANADA NEXT-GENERATION IVD MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 284. CANADA NEXT-GENERATION IVD MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 285. CANADA NEXT-GENERATION IVD MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 286. CANADA NEXT-GENERATION IVD MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 287. CANADA NEXT-GENERATION IVD MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 288. CANADA NEXT-GENERATION IVD MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 289. MEXICO NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 290. MEXICO NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 291. MEXICO NEXT-GENERATION IVD MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 292. MEXICO NEXT-GENERATION IVD MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 293. MEXICO NEXT-GENERATION IVD MARKET SIZE, BY REAGENTS & KITS, 2018-2024 (USD MILLION)
TABLE 294. MEXICO NEXT-GENERATION IVD MARKET SIZE, BY REAGENTS & KITS, 2025-2030 (USD MILLION)
TABLE 295. MEXICO NEXT-GENERATION IVD MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
TABLE 296. MEXICO NEXT-GENERATION IVD MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2030 (USD MILLION)
TABLE 297. MEXICO NEXT-GENERATION IVD MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 298. MEXICO NEXT-GENERATION IVD MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 299. MEXICO NEXT-GENERATION IVD MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2024 (USD MILLION)
TABLE 300. MEXICO NEXT-GENERATION IVD MARKET SIZE, BY CLINICAL CHEMISTRY, 2025-2030 (USD MILLION)
TABLE 301. MEXICO NEXT-GENERATION IVD MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 302. MEXICO NEXT-GENERATION IVD MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 303. MEXICO NEXT-GENERATION IVD MARKET SIZE, BY MICROBIOLOGY, 2018-2024 (USD MILLION)
TABLE 304. MEXICO NEXT-GENERATION IVD MARKET SIZE, BY MICROBIOLOGY, 2025-2030 (USD MILLION)
TABLE 305. MEXICO NEXT-GENERATION IVD MARKET SIZE, BY MOLECULAR DIAGNOSTIC, 2018-2024 (USD MILLION)
TABLE 306. MEXICO NEXT-GENERATION IVD MARKET SIZE, BY MOLECULAR DIAGNOSTIC, 2025-2030 (USD MILLION)
TABLE 307. MEXICO NEXT-GENERATION IVD MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 308. MEXICO NEXT-GENERATION IVD MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 309. MEXICO NEXT-GENERATION IVD MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
TABLE 310. MEXICO NEXT-GENERATION IVD MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2030 (USD MILLION)
TABLE 311. MEXICO NEXT-GENERATION IVD MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2024 (USD MILLION)
TABLE 312. MEXICO NEXT-GENERATION IVD MARKET SIZE, BY HOSPITALS & CLINICS, 2025-2030 (USD MILLION)
TABLE 313. MEXICO NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 314. MEXICO NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 315. MEXICO NEXT-GENERATION IVD MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2024 (USD MILLION)
TABLE 316. MEXICO NEXT-GENERATION IVD MARKET SIZE, BY AUTOIMMUNE DISEASES, 2025-2030 (USD MILLION)
TABLE 317. MEXICO NEXT-GENERATION IVD MARKET SIZE, BY CARDIOLOGY, 2018-2024 (USD MILLION)
TABLE 318. MEXICO NEXT-GENERATION IVD MARKET SIZE, BY CARDIOLOGY, 2025-2030 (USD MILLION)
TABLE 319. MEXICO NEXT-GENERATION IVD MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 320. MEXICO NEXT-GENERATION IVD MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 321. MEXICO NEXT-GENERATION IVD MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 322. MEXICO NEXT-GENERATION IVD MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 323. MEXICO NEXT-GENERATION IVD MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 324. MEXICO NEXT-GENERATION IVD MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 325. MEXICO NEXT-GENERATION IVD MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 326. MEXICO NEXT-GENERATION IVD MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 327. MEXICO NEXT-GENERATION IVD MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 328. MEXICO NEXT-GENERATION IVD MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 329. BRAZIL NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 330. BRAZIL NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 331. BRAZIL NEXT-GENERATION IVD MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 332. BRAZIL NEXT-GENERATION IVD MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 333. BRAZIL NEXT-GENERATION IVD MARKET SIZE, BY REAGENTS & KITS, 2018-2024 (USD MILLION)
TABLE 334. BRAZIL NEXT-GENERATION IVD MARKET SIZE, BY REAGENTS & KITS, 2025-2030 (USD MILLION)
TABLE 335. BRAZIL NEXT-GENERATIO

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Next-Generation IVD market report include:
  • F. Hoffmann-La Roche Ltd.
  • Abbott Laboratories
  • Siemens Healthineers AG
  • Danaher Corporation
  • Thermo Fisher Scientific Inc.
  • Becton, Dickinson and Company
  • bioMérieux SA
  • Sysmex Corporation
  • QIAGEN N.V.
  • Mindray Medical International Limited

Table Information

Report AttributeDetails
No. of Pages184
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 69.24 Billion
Forecasted Market Value ( USD ) by 2030 $ 89.44 Billion
Compound Annual Growth Rate5.3%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Calprotectin Test Kit for IVD Market by Technology (Chemiluminescence Immunoassay, Enzyme Immunoassay, Fluorescence Immunoassay), Test Type (Qualitative, Quantitative), End User, Application, Distribution Channel, Product Format - Global Forecast 2025-2030 - Product Image

Calprotectin Test Kit for IVD Market by Technology (Chemiluminescence Immunoassay, Enzyme Immunoassay, Fluorescence Immunoassay), Test Type (Qualitative, Quantitative), End User, Application, Distribution Channel, Product Format - Global Forecast 2025-2030

  • Report
  • 183 Pages
  • Global
From
In Vitro Diagnostics Market by Product & Service (Kits, Instruments), Technology (Immunoassay, Hematology, Glucose Monitoring), Specimen (Blood), Site of Testing, Application (Endocrinology, Cardiology, Infectious Diseases) & Region- Global Forecast to 2030 - Product Image

In Vitro Diagnostics Market by Product & Service (Kits, Instruments), Technology (Immunoassay, Hematology, Glucose Monitoring), Specimen (Blood), Site of Testing, Application (Endocrinology, Cardiology, Infectious Diseases) & Region- Global Forecast to 2030

  • Report
  • 740 Pages
  • Global
From
Clinical Chemistry and Immunoassay Industry, Global, 2023-2028 - Product Image

Clinical Chemistry and Immunoassay Industry, Global, 2023-2028

  • Report
  • Global
From
In-Vitro Diagnostics Quality Control Market by Product Type (Analyzers & Instruments, Control Materials, QC Reagents), Technology (Clinical Chemistry, Hematology, Immunoassay), Application, End User - Global Forecast 2025-2030 - Product Image

In-Vitro Diagnostics Quality Control Market by Product Type (Analyzers & Instruments, Control Materials, QC Reagents), Technology (Clinical Chemistry, Hematology, Immunoassay), Application, End User - Global Forecast 2025-2030

  • Report
  • 185 Pages
  • Global
From
Immunoassay Interference Blocker - Global Strategic Business Report - Product Image

Immunoassay Interference Blocker - Global Strategic Business Report

  • Report
  • 470 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.